INSM INSMED INC revenue, earnings and financials
For the quarter ended June 30, 2026, INSMED INC reported revenue of $425M (up 296.1% from a year earlier), net income of −$13.2M and diluted EPS of −$0.06; over the last four quarters revenue was $1.14B and net income −$875M; for the fiscal year ended December 2025 revenue was $606M, up 66.7% on the year before.
INSM annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $606M, gross profit n/a, operating income −$1.25B, net income −$1.28B (margin -210.5%), EPS −$6.42
- Fiscal year ended Dec 2024: revenue $364M, gross profit n/a, operating income −$878M, net income −$914M (margin -251.2%), EPS −$5.57
- Fiscal year ended Dec 2023: revenue $305M, gross profit n/a, operating income −$710M, net income −$750M (margin -245.6%), EPS −$5.34
- Fiscal year ended Dec 2022: revenue $245M, gross profit n/a, operating income −$457M, net income −$482M (margin -196.3%), EPS −$3.91
- Fiscal year ended Dec 2021: revenue $188M, gross profit n/a, operating income −$375M, net income −$435M (margin -230.6%), EPS −$3.88
INSM quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $425M (up 296.1% year over year), net income −$13.2M, EPS −$0.06
- Quarter ended Mar 31, 2026: revenue $306M (up 229.6% year over year), net income −$164M, EPS −$0.76
- Quarter ended Dec 31, 2025 (from the annual report): revenue $264M (up 152.6% year over year), net income −$328M, EPS −$1.55
- Quarter ended Sep 30, 2025: revenue $142M (up 52.4% year over year), net income −$370M, EPS −$1.75
- Quarter ended Jun 30, 2025: revenue $107M (up 18.9% year over year), net income −$322M, EPS −$1.70
- Quarter ended Mar 31, 2025: revenue $92.8M (up 22.9% year over year), net income −$257M, EPS −$1.42
- Quarter ended Dec 31, 2024 (from the annual report): revenue $104M (up 24.8% year over year), net income −$236M, EPS −$1.30
- Quarter ended Sep 30, 2024: revenue $93.4M (up 18.2% year over year), net income −$221M, EPS −$1.27
- Quarter ended Jun 30, 2024: revenue $90.3M (up 17.0% year over year), net income −$301M, EPS −$1.94
- Quarter ended Mar 31, 2024: revenue $75.5M (up 15.8% year over year), net income −$157M, EPS −$1.06
- Quarter ended Dec 31, 2023 (from the annual report): revenue $83.7M (up 41.1% year over year), net income −$186M, EPS −$1.28
- Quarter ended Sep 30, 2023: revenue $79.1M (up 16.7% year over year), net income −$159M, EPS −$1.11
- Quarter ended Jun 30, 2023: revenue $77.2M (up 18.4% year over year), net income −$245M, EPS −$1.78
- Quarter ended Mar 31, 2023: revenue $65.2M (up 22.8% year over year), net income −$160M, EPS −$1.17
- Quarter ended Dec 31, 2022 (from the annual report): revenue $59.3M (up 5.7% year over year), net income −$160M, EPS −$1.22
- Quarter ended Sep 30, 2022: revenue $67.7M (up 44.9% year over year), net income −$131M, EPS −$1.09
- Quarter ended Jun 30, 2022: revenue $65.2M (up 43.8% year over year), net income −$95.6M, EPS −$0.80
- Quarter ended Mar 31, 2022: revenue $53.1M (up 32.1% year over year), net income −$94.6M, EPS −$0.80
- Quarter ended Dec 31, 2021 (from the annual report): revenue $56.1M, net income −$113M, EPS −$0.96
- Quarter ended Sep 30, 2021: revenue $46.8M, net income −$113M, EPS −$0.96
INSM cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$935M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$684M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$536M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$400M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$363M, share buybacks n/a
INSM balance sheet
- Jun 30, 2026: cash $545M, total assets $2.10B, total liabilities $1.35B, shareholders' equity $757M, long-term debt $544M
- Mar 31, 2026: cash $582M, total assets $2.08B, total liabilities $1.37B, shareholders' equity $705M, long-term debt $542M
- Dec 31, 2025: cash $510M, total assets $2.26B, total liabilities $1.53B, shareholders' equity $739M, long-term debt $541M
- Sep 30, 2025: cash $335M, total assets $2.36B, total liabilities $1.42B, shareholders' equity $946M, long-term debt $540M
- Jun 30, 2025: cash $1.28B, total assets $2.48B, total liabilities $1.23B, shareholders' equity $1.25B, long-term debt $539M
- Mar 31, 2025: cash $403M, total assets $1.80B, total liabilities $1.70B, shareholders' equity $99.2M, long-term debt $1.11B
- Dec 31, 2024: cash $555M, total assets $2.03B, total liabilities $1.74B, shareholders' equity $285M, long-term debt $1.10B
- Sep 30, 2024: cash $461M, total assets $2.05B, total liabilities $1.57B, shareholders' equity $483M, long-term debt $955M
What is INSM's revenue?
INSMED INC reported $1.14B of revenue over its last four quarters, through June 30, 2026.
Is INSM profitable?
No. INSMED INC lost $875M over the last four quarters.
What is INSM's EPS?
Diluted earnings per share over the last four quarters were −$4.12; −$0.06 in the latest quarter.